Safety and Immunogenicity of Live Attenuated and Inactivated Influenza Vaccines in Children With Cancer-Reference-Cited by-同舟云学术

Safety and Immunogenicity of Live Attenuated and Inactivated Influenza Vaccines in Children With Cancer

Published:2011-09-23 Issue:10 Volume:204 Page:1475-1482
ISSN:1537-6613
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Carr Silvana,Allison Kim J.,Van De Velde Lee–Ann,Zhang Kelly,English Elizabeth Y.,Iverson Amy,Daw Najat C.,Howard Scott C.,Navid Fariba,Rodriguez-Galindo Carlos,Yang Jie,Adderson Elisabeth E.,McCullers Jonathan A.,Flynn Patricia M.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/204/10/1475/18064843/jir561.pdf

Reference44 articles.

1. Influenza in children. Relationship to other respiratory agents;Glezen;JAMA,1980

2. The burden of influenza illness in children with asthma and other chronic medical conditions;Neuzil;J Pediatr,2000

3. Parainfluenza and influenza virus infections in pediatric organ transplant recipients;Apalsch;Clin Infect Dis,1995

4. Influenza in children with cancer;Kempe;J Pediatr,1989

5. Influenza in children and young adults with cancer: 20 cases;Feldman;Cancer,1977

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Vaccine Immunogenicity—Correlates to Real-World Protection: Influenza;Viruses;2024-03-12

2. Reducedhumoral response against variants of concern in childhood solid cancer patients compared to adult patients and healthy children after SARS-CoV-2 vaccination;Frontiers in Immunology;2023-05-25

3. Therapeutic Vaccination in Head and Neck Squamous Cell Carcinoma—A Review;Vaccines;2023-03-13

4. Lessons learnt from influenza vaccination in immunocompromised children undergoing treatment for cancer;The Lancet Child & Adolescent Health;2023-03

5. Challenges in the manufacture, storage, distribution and regulation of traditional and novel vaccines;Generics and Biosimilars Initiative Journal;2022-04-15